Taiwan’s plan to create new regulatory body moves closer to reality
This article was originally published in SRA
Executive Summary
Two Taiwanese legislative committees have jointly approved a draft bill put forth by the country’s executive branch (the Executive Yuan) to establish a new Food and Drug Administration office that would bring a number of key regulatory and product safety activities under one roof1,2. For the Taiwan FDA (TFDA) to become functional, the bill now has to be cleared by the Legislative Yuan.
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.